Schonfeld Strategic Advisors LLC Morphic Holding, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $14 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$21.33 - $59.42 $1.69 Million - $4.72 Million
79,398 Added 272.83%
108,500 $2.49 Million
Q2 2023

Aug 14, 2023
SELL
$34.33 - $62.11 $147,413 - $266,700
-4,294 Reduced 12.86%
29,102 $1.67 Million
Q1 2023

May 15, 2023
BUY
$26.01 - $48.69 $665,751 - $1.25 Million
25,596 Added 328.15%
33,396 $1.26 Million
Q4 2022

Feb 14, 2023
SELL
$24.14 - $30.37 $506,384 - $637,071
-20,977 Reduced 72.9%
7,800 $208,000
Q3 2022

Nov 14, 2022
BUY
$22.23 - $33.37 $639,712 - $960,288
28,777 New
28,777 $815,000

Others Institutions Holding MORF

# of Institutions
142
Shares Held
37.9M
Call Options Held
13.5K
Put Options Held
190K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email